Resveratrol is attracting much interest because of its potential to decrease
body weight and increase life span, influencing liver and muscle function by increasing mitochondrial mass and energy expenditure. Even though
resveratrol was already shown to reduce the adipose tissue mass in animal models, its effects on mitochondrial mass and network structure in adipocytes have not yet been studied. For this purpose, we investigated the effect of
resveratrol on mitochondrial mass increase and remodeling during adipogenic differentiation of two in vitro models of adipocyte biology, the murine 3T3-L1 cell line and the human SGBS cell strain. We confirm that
resveratrol inhibits lipogenesis in differentiating adipocytes, both mouse and human. We further show that this is linked to inhibition of the normally observed mitochondrial mass increase and mitochondrial remodeling. At the molecular level, the anti-lipogenic effect of
resveratrol seems to be mediated by a blunted expression increase and an inhibition of
acetyl-CoA carboxylase (ACC). This is one of the consequences of an inhibited
insulin-induced signaling via Akt, and maintained signaling via
AMP-activated protein kinase. The anti-lipogenic effect of
resveratrol is further modulated by expression levels of mitochondrial ATAD3, consistent with the emerging role of this
protein as an important regulator of mitochondrial biogenesis and lipogenesis. Our data suggest that
resveratrol acts on differentiating preadipocytes by inhibiting
insulin signaling, mitochondrial biogenesis, and lipogenesis, and that
resveratrol-induced reduction of mitochondrial biogenesis and
lipid storage contribute to adipose tissue
weight loss in animals and humans.